Description

MOTS-c (human) peptide (CAS 1627580-64-6) is a synthetic mitochondrial-derived peptide encoded by the mitochondrial genome. It plays a crucial role in regulating metabolic homeostasis and enhancing physical performance. MOTS-c activates AMP-activated protein kinase (AMPK), leading to improved insulin sensitivity, increased glucose uptake, and potential anti-obesity effects. It also exhibits anti-inflammatory properties by modulating various signaling pathways. MOTS-c has been studied for its potential applications in aging, metabolic disorders, and cardiovascular health. Synthesized under GMP conditions with a purity of ?99.90%, it ensures high-quality material for pharmaceutical and biochemical research.

MOTS-c (Human) Product Specifications

MOTS-c (Human) Mechanism of Action & Research Applications

MOTS-c (human) peptide functions as a mitochondrial-derived peptide that activates AMPK, leading to enhanced glucose uptake and improved insulin sensitivity. It also modulates various signaling pathways, including the MAP kinase/c-Fos pathway, to exert anti-inflammatory effects. MOTS-c has been studied for its potential applications in aging, metabolic disorders, and cardiovascular health. Its high purity and GMP manufacturing ensure reliability in experimental settings.

Side Effects (For Reference Only)

As MOTS-c (human) peptide is intended solely for laboratory research, its safety profile in humans is not fully established. Preliminary studies suggest that potential side effects may include mild metabolic alterations if applied in vivo, but no comprehensive toxicology data is available. Researchers are advised to handle the peptide according to laboratory safety guidelines and avoid human administration.

Disclaimer

MOTS-c (Human) This product is intended strictly for laboratory research use only. It is not approved for human or veterinary use. Please adhere to institutional safety protocols when handling.